FDA Inspection 1178562 — Columbia University Medical Center IRB

Columbia University Medical Center IRB — FEI 2435189

The FDA completed an inspection of Columbia University Medical Center IRB on August 31, 2022 in New York, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 31, 2022
Fiscal Year
2022
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
New York, NY (United States)

Additional Details

IRB

Citations

IDCFRDescription
729021 CFR 56.108(c)Members present for review
731821 CFR 56.115(a)(2)Minutes of IRB meetings